Evidence map›Paper›PMID 38870470›Full record

SynthesisNeurology2024

Measuring Health-Related Quality of Life in Amyotrophic Lateral Sclerosis: A Systematic Review and Conceptual Framework.

Emily McDool, Jill Carlton, Philip A Powell, Elizabeth Coates, Liam Knox, Emily Mayberry, Niamh Appleby, Alys W Griffiths, Esther Hobson, Christopher J McDermott

Abstract readSystematic Review
In one paragraph

Synthesis in Neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emily McDoolFrom the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom.
Jill CarltonFrom the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0002-9373-7663
Philip A PowellFrom the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0003-1169-3431
Elizabeth CoatesFrom the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom.
Liam KnoxFrom the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom.
Emily MayberryFrom the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom.
Niamh ApplebyFrom the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom.
Alys W GriffithsFrom the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom.
Esther HobsonFrom the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom.
Christopher J McDermottFrom the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0002-1269-9053

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe assessment of health-related quality of life (HRQoL) in patients with amyotrophic lateral sclerosis (ALS) is heterogeneous and inconsistent. The objectives of this study were (1) to develop a comprehensive conceptual framework of HRQoL in ALS and (2) map the content of existing patient-reported outcome measures (PROMs) used in ALS to this novel framework.

methodsOur model of HRQoL in ALS (Health-related Quality of life in Amyotrophic Lateral Sclerosis, QuALS) was developed from a systematic literature review and consultative input from key stakeholders (patients, carers, and health care professionals). Five electronic databases were searched in April 2022. Primary studies of any design that assessed HRQoL in ALS by using a multi-item PROM and/or qualitative methods were identified. Using an a priori framework, HRQoL themes were extracted and iteratively modified from the content of each PROM and qualitative study quotations identified in the literature. The conceptual framework was ratified by stakeholders with lived experience and clinical experts. The QuALS framework was used to map the content of identified PROMs and qualitative studies based on thematic coverage.

resultsQuALS covers 3 high-level domains of HRQoL (physical, psychological, and social functioning) and consists of 7 themes (Activities; Physical Health; Autonomy; Cognition; Feelings and Emotions; Self-identity; Relationships), characterized by 42 subthemes. Of 8,220 studies identified, 274 were included in the review that informed QuALS. In these studies, 111 PROMs were used to assess at least 1 aspect of HRQoL, and 11 studies used qualitative methods. Of the 3 high-level domains, physical functioning was the most commonly assessed, particularly within ALS-specific PROMs where almost one-quarter of PROMs exclusively assessed physical functioning. None of the PROMs or qualitative studies identified assessed all aspects of HRQoL in the QuALS framework. DISCUSSION: This study presents a new comprehensive conceptual framework of HRQoL in ALS (QuALS), informed by a robust systematic review of existing literature and stakeholder input, incorporating lived experience. QuALS provides a valuable resource for researchers and clinicians interested in taking a holistic approach to assessing and understanding the full impact of ALS on HRQoL and how this may be affected by treatments.

Indexed as

Amyotrophic Lateral SclerosisQuality of LifeHumansPatient Reported Outcome Measures

Identifiers

PMID38870470
PMCPMC11244752

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.